News + Filings Transactions
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
|
|
Hughes Owen
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 10/04/2023 |
4
| Hughes Owen (Exec Chairman and Interim CEO) has filed a Form 4 on XOMA Corp|
Txns:
| Bought 1,000 shares
@ $13.83, valued at
$13.8k
|
|
| 09/27/2023 |
4
| Hughes Owen (Exec Chairman and Interim CEO) has filed a Form 4 on XOMA Corp|
Txns:
| Bought 1 shares
@ $14.65, valued at
$14.7
Bought 2,499 shares
@ $14.43, valued at
$36.1k
|
|
| 05/25/2023 |
4
| Hughes Owen (Interim CEO) has filed a Form 4 on XOMA Corp|
Txns:
| Bought 200 shares
@ $23.33, valued at
$4.7k
Bought 768 shares
@ $23.49, valued at
$18k
Bought 1,032 shares
@ $23.79, valued at
$24.6k
|
|
| 01/06/2023 |
3
| Hughes Owen (Interim CEO) has filed a Form 3 on XOMA Corp |
| 01/05/2023 |
4
| Hughes Owen (Interim CEO) has filed a Form 4 on XOMA Corp|
Txns:
| Granted 100,000 options to buy
@ $18.66, valued at
$1.9M
Granted 75,000 options to buy
@ $30, valued at
$2.3M
|
|
| 12/19/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 12/19/2022 |
3
| Form 3 - Initial statement of beneficial ownership of securities: |
| 08/15/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 01/25/2022 |
4
| Hughes Owen (Director) has filed a Form 4 on Radius Health, Inc.|
Txns:
| Granted 5,500 shares
@ $0
Granted 10,000 options to buy
@ $6.4, valued at
$64k
|
|
| 12/30/2021 |
4/A
| Hughes Owen (Director) has filed a Form 4 on PARDES BIOSCIENCES, INC.|
Txns:
| Converted 30,000 shares
@ $0
Converted 30,000 options to buy
@ $0 |
|
| 12/28/2021 |
4
| Hughes Owen (Director) has filed a Form 4 on PARDES BIOSCIENCES, INC.|
Txns:
| Converted 52,500 shares
@ $0
Converted 52,500 options to buy
@ $0 |
|
| 09/14/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/16/2021 |
4
| Hughes Owen (Director) has filed a Form 4 on Translate Bio, Inc.|
Txns:
| Granted 20,000 options to buy
@ $20.43, valued at
$408.6k
|
|
| 02/23/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/16/2021 |
3
| Form 3 - Initial statement of beneficial ownership of securities: |
| 01/25/2021 |
4
| Hughes Owen (Director) has filed a Form 4 on Radius Health, Inc.|
Txns:
| Granted 40,000 options to buy
@ $22, valued at
$880k
|
|
| 01/14/2021 |
4
| Hughes Owen (President and CEO) has filed a Form 4 on Cullinan Management, Inc.|
Txns:
| Bought 2,500 shares
@ $21, valued at
$52.5k
|
|
| 01/11/2021 |
4
| Hughes Owen (President and CEO) has filed a Form 4 on Cullinan Management, Inc.|
Txns:
| Granted 433,332 options to buy
@ $21, valued at
$9.1M
|
|
| 01/07/2021 |
3
| Form 3 - Initial statement of beneficial ownership of securities: |
| 06/16/2020 |
4
| Hughes Owen (Director) has filed a Form 4 on Translate Bio, Inc.|
Txns:
| Granted 18,900 options to buy
@ $15.33, valued at
$289.7k
|
|
| 02/28/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/24/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/19/2019 |
4
| Hughes Owen (Director) has filed a Form 4 on Translate Bio, Inc.|
Txns:
| Granted 18,900 options to buy
@ $10.2, valued at
$192.8k
|
|
| 04/18/2019 |
4
| Hughes Owen (Director) has filed a Form 4 on Radius Health, Inc.|
Txns:
| Sold 2,400 shares
@ $22.22, valued at
$53.3k
|
|
| 02/26/2019 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/13/2019 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/27/2018 |
3
| Hughes Owen (Director) has filed a Form 3 on Translate Bio, Inc. |
| 02/15/2018 |
4
| Hughes Owen (Director) has filed a Form 4 on Radius Health, Inc.|
Txns:
| Granted 8,800 options to buy
@ $37.83, valued at
$332.9k
Granted 4,800 restricted stock units
@ $0 |
|
| 02/22/2017 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 06/02/2016 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 05/03/2013 |
3
| Form 3 - Initial statement of beneficial ownership of securities |
|
|